Skip to main content
Article thumbnail
Location of Repository

The Changing Scientific and Technological Basis of the CBW Proliferation Problem

By A. Kelle

Abstract

Ye

Topics: BTWC, Biological and Toxin Weapons Convention, CBW, Chemical and Biological Weapons, Biological Warfare, Chemical Warfare, Biological Agents, Bioterrorism
Year: 2007
OAI identifier: oai:bradscholars.brad.ac.uk:10454/803
Provided by: Bradford Scholars

Suggested articles

Citations

  1. (2004a) ‘Cancer as a robust system: Implications for anticancer therapy’, doi
  2. (2004b) ‘Biological robustness’,
  3. (2000). A doi
  4. (1992). A novel (chloropyridyl)azabicycloheptane with potent analgesic activity from an Ecuadorian poison frog’, doi
  5. (2002). Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness’, doi
  6. (1999). Bacterial Artificial Chromosomes’, doi
  7. (1999). Biological Weapons in the Former Soviet Union: An Interview with Dr. Kenneth Alibek’, doi
  8. (1997). Biomedical applications of nanotechnology – implications for drug targeting and gene therapy’, doi
  9. (2002). Biotechnology and Biochemical Weapons’, The Nonproliferation Review, doi
  10. (2002). Chemical synthesis in microreactors’, doi
  11. (2002). Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template’, doi
  12. (2001). Chemoinformatics; manipulating chemical information to facilitate decisionmaking in drug discovery’, doi
  13. (2002). Combinatorial Chemistry in perspective’ doi
  14. (2000). Combinatorial Libraries and High-Throughput Synthesis’ doi
  15. (2004). Comparative Genomics at the Vertebrate Extremes’, Nature Reviews: Genetics, doi
  16. (1993). Comparative protein modelling by satisfaction of spatial restrains’, doi
  17. (2004). Controlling Biochemical Weapons. Adapting Multilateral Arms Control for the 21 st Century,
  18. (2004). Controlling Biochemical Weapons. Adapting Multilateral Arms Control for the 21st Century,
  19. (2000). Definition of nanotechnology,
  20. (2003). Disease Proteomics’, doi
  21. (2006). Draft Final Document, doi
  22. (2003). EMBL Data Library of the European Molecular Biology Laboratory
  23. (2003). EMBL Data Library of the European Molecular Biology Laboratory in
  24. (1986). Engines of Creation: The Coming Era of Nanotechnology,
  25. (1995). Establishing a Human Transcript Map’, doi
  26. (1999). Fluorescence-based DNA Sequencing’, in
  27. (2000). Functional discovery via a compendium of expression profiles’, doi
  28. (1971). General Assembly doi
  29. (2000). Genetics, Genomics and Drug Discovery’, doi
  30. (1997). High Throughput Fingerprint Analysis of Large-Insert Clones’,
  31. (2004). http://www.nature.com/nature/focus/accessdebate/index.html The C. elegans Sequencing Consortium
  32. (1998). Importance of Anchor Genomes for any Plant Genome Project’, doi
  33. (2002). Introduction to Combinatorial Chemistry’ doi
  34. (2004). LabelFree Protein and Pathogen Detection Using the Atomic Force Microscope’,
  35. (2004). Maximizing the Potential of Functional Genomics’, Nature Reviews: Genetics, doi
  36. (2006). Modest Progress at the Sixth Review Conference’, available at http://www.bwc06.org/ entry dated 11
  37. (1992). Molecular Dynamics simulations, Wiley Interscience.
  38. (1996). Molecular Modelling: Principles and Applications,
  39. (2002). Multi-axis robots bring automation to life sciences’, doi
  40. (2004). NANO, doi
  41. (2005). Nanomedicine: current status and future prospects’, doi
  42. (2004). Nanoscience and nanotechnologies: opportunities and uncertainties, London, 29 July, available online at http://www.nanotec.org.uk/finalReport.htm Sahoo,
  43. (2002). Nanotechnology, Basic science and emerging technologies, doi
  44. (2002). New developments in anti-HIV chemotherapy’, doi
  45. (2005). Nucleic acids as drug targets’ in An Introduction to Medicinal Chemistry,
  46. (2006). Opening Statement by the Director General to the Conference of the States Parties at its Eleventh Session, The Hague: OPCW,
  47. (1995). Paclitaxel- from discovery to clinic’, doi
  48. (2000). Pharmacophore identification and receptor mapping’ doi
  49. (2006). Preparatory Committee for the 6 th BWC Review Conference
  50. (2006). Preparatory Committee for the 6th BWC Review Conference
  51. (2002). Proteomics: An Infinite Problem with an Infinite Potential’, The Scientist,
  52. (2003). Proteomics: The First Decade and Beyond’, Nature Genetics Supplement, doi
  53. (2005). Protozoan genomics for drug discovery’, doi
  54. (2006). Review Conference
  55. (2006). Scientia Corrupta: The Life Sciences and Biological Weapons’,
  56. (2002). Solution phase synthesis of β-peptides using micro reactors’, doi
  57. (2001). The Global Technology Revolution. Bio/Nano/Materials Trends and Their Synergies with Information Technology by 2015, Prepared for the National Intelligence Council,
  58. The National Academies (2004) Biotechnology Research in the Age of Terrorism,
  59. The National Academies (2005) An International Perspective on Advancing technologies and Strategies for Managing Dual-Use Risks,
  60. (1998). The Negotiations on the Chemical Weapons Convention: a historical overview’,
  61. (1971). The Rise of CB Weapons, Vol.I in the series The Problem of Chemical and Biological Warfare,
  62. (1960). There is Plenty of Room at the Bottom’, Engineering and Science, Vol.23, pp.22-36, available online at http://www.zyvex.com/nanotech/feynman.html
  63. (2000). Trends in Analytical Chemistry, 19; 396 Meng, doi
  64. (2003). using bioinformatics in gene and drug discovery’, Drug Discovery Today, doi
  65. (1995). Vom Giftpfeil zum Chemiewaffenverbot – Zur Geschichte der chemischen Kampfmittel, Frankfurt/Main:

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.